10x Genomics, founded in 2012 by Serge Saxonov, is a public biotechnology company based in Pleasanton, California. The company develops and manufactures genomics analysis platforms and instruments that enable researchers to study individual cells and tissues at the molecular level. Flagship products include the Chromium platform for single-cell analysis and Visium for spatial transcriptomics. With approximately 3,000 employees, 10x Genomics serves academic research institutions, clinical laboratories, and pharmaceutical companies globally. The company went public in January 2021 on NASDAQ and is recognized as a leader in democratizing access to advanced genomics technologies.
10x Genomics fosters a culture centered on scientific innovation and enabling discovery through advanced tools. The company attracts scientists, engineers, and business professionals passionate about genomic research and committed to making powerful technologies accessible to the broader research community. Leadership emphasizes rigorous science, customer success, and continuous learning, creating a collaborative environment. As a recently public company, 10x benefits from resources to invest in employee development while maintaining the innovation focus of its growth stage.
40 open now, 40 first appeared in the last 30d.